Status:
UNKNOWN
Neuromodulation of Inhibitory Control in Tic Disorders
Lead Sponsor:
IRCCS Eugenio Medea
Conditions:
Tic Disorders
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The present study aims to assess the effects of non invasive electrical stimulation of the vagus nerve via transcutaneous vagus nerve stimulation (tVNS) on cognitive functions, inhibitory and tic cont...
Detailed Description
The investigators planned a single centre, randomized, double-blind, sham- controlled, crossover (within subject) design. Adults with Tic Disorders will be recruited and randomly assigned to two diff...
Eligibility Criteria
Inclusion
- adults who aged 18-50 years;
- Diagnosis of Tic disorders
Exclusion
- Presence of contraindication to tVNS (history of epilepsy in the last two years, severe brain trauma; presence of metal in the brain/skull or implanted neurostimulator, cardiac pacemaker; state of pregnancy);
- Recent changes in drugs therapy due to the intake of or the withdrawal from some drugs potentially changing the seizure threshold;
- Presence of comorbidity with an important medical condition;
- Severe sensorial, motor and/or behavioural problems that could interfere with the tasks
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05263414
Start Date
June 1 2022
End Date
April 30 2023
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute, IRCCS E. Medea,
Pasian di Prato, Udine, Italy, 33037